The Royal Marsden Hospital is a specialist cancer treatment hospital in London based in Kensington and Chelsea, next to the Royal Brompton Hospital, in Fulham Road with a second site in Belmont, close to Sutton Hospital, High Down and Downview Prisons. It is managed by the Royal Marsden NHS Foundation Trust.

There are 269 beds in Institute of Cancer Research and Royal Marsden Hospital.

During the past decade, Institute of Cancer Research and Royal Marsden Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Cancer Research and Royal Marsden Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 11 trials, followed by "Abbott" with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Ultimovacs ASA" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Cancer Research and Royal Marsden Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "Royal Marsden NHS Foundation Trust" with 4 trials as a collaborator, "East and North Hertfordshire NHS Trust" with 2 trials as a collaborator, "Imperial College Healthcare NHS Trust" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Cancer Research and Royal Marsden Hospital" are "Prostate Cancer" (6 trials), "Cancer" (2 trials), "Advanced Ovarian Cancer" (1 trials), "BRCA Mutated" (1 trials) and "BRCA Mutation" (1 trials). Many other conditions were trialed in "Institute of Cancer Research and Royal Marsden Hospital" in a lesser frequency.

Most popular intervention types in "Institute of Cancer Research and Royal Marsden Hospital" are "Drug" (6 trials), "Other" (5 trials), "Procedure" (4 trials), "Genetic" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials), "Genetic SNP profiling" (2 trials), "Olaparib 300mg tablets" (2 trials), "Prostate biopsy" (2 trials) and "Prostate cancer screening" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Cancer Research and Royal Marsden Hospital" are 8 trials for "Male" genders, 5 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Cancer Research and Royal Marsden Hospital". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Institute of Cancer Research and Royal Marsden Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Cancer Research and Royal Marsden Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".